Ligand Binding and Subtype Selectivity of the Human A2A Adenosine Receptor
Open Access
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (17) , 13032-13044
- https://doi.org/10.1074/jbc.m109.096974
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor AntagonistsJournal of Medicinal Chemistry, 2010
- ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and DrugsAnnual Review of Pharmacology and Toxicology, 2005
- Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and AntagonistsJournal of Medicinal Chemistry, 2003
- Site-directed mutagenesis studies of human A2A adenosine receptorsBiochemical Pharmacology, 2000
- 5‘-N-Substituted Carboxamidoadenosines as Agonists for Adenosine ReceptorsJournal of Medicinal Chemistry, 1999
- Mutagenesis Reveals Structure−Activity Parallels between Human A2AAdenosine Receptors and Biogenic Amine G Protein-Coupled ReceptorsJournal of Medicinal Chemistry, 1997
- Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.1996
- Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.1996
- Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine ReceptorJournal of Biological Chemistry, 1995
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973